(Q35695543)

9 August 2017

1 reference

title

Advances in radiochemotherapy in the treatment of head and neck cancer (English)

1 reference

9 August 2017

0 references

head and neck carcinoma

1 reference

Daniel Herchenhorn

1

1 reference

9 August 2017

Fernando Luiz Dias

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Revista do Hospital das Clinicas

9 August 2017

published in

1 reference

9 August 2017

volume

59

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

39-46

1 reference

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Gene therapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812004000100007

10.1590/S0041-87812004000100007

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference